{"id":"W4391091316","doi":"10.1200/jco.2024.42.3_suppl.tps243","title":"NRG-GI008: Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"Natera","keywords":"Medicine; Irinotecan; Internal medicine; Oxaliplatin; Oncology; Cohort; Regimen; Chemotherapy; Clinical endpoint; Randomized controlled trial; Colorectal cancer; Prospective cohort study; Cancer; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004026552,0.0003477,0.0003813915,0.0002334348,0.0001066203,0.0002341251,0.0004021592,0.0004212557,0.008635772],"category_scores_gemma":[0.0003836431,0.0001164248,0.0002669547,0.0002841477,0.0001962354,0.0001609337,0.0002748186,0.0008659909,0.001702032],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005010441,"about_ca_system_score_gemma":0.000842768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00103039,"about_ca_topic_score_gemma":0.004369413,"domain_scores_codex":[0.9998794,0.00005399234,0.000005040976,0.00002363051,0.00001927217,0.00001871661],"domain_scores_gemma":[0.9997936,0.00002767211,0.00004974311,0.00001751561,0.00001855557,0.00009293636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.06829827,0.004183273,0.02033752,0.001350865,0.0003388507,0.0005718126,0.00007074099,0.001643456,0.03851761,0.001611505,0.06806765,0.7950084],"study_design_scores_gemma":[0.1699008,0.1972523,0.1842901,0.001481671,0.001592171,0.007940708,0.0001359779,0.006086578,0.0218858,0.002411884,0.4069056,0.0001163382],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8314648,0.05046324,0.003673464,0.008078107,0.001226331,0.003729473,0.007791307,0.001519269,0.09205404],"genre_scores_gemma":[0.9266358,0.01536834,0.01091231,0.004090109,0.0003924511,0.002336286,0.01026766,0.000184952,0.02981203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008635772,"threshold_uncertainty_score":0.02888948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0788650787455616,"score_gpt":0.4455083510090546,"score_spread":0.366643272263493,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}